Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$252,801
-$146,306 QoQ
Shares Held
155,093
-36.7% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,393,117,077 across 362 Biotechnology names. CDXS ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | INCY |
Incyte Corp
|
367,095 | $34,550,980 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $252,801 | 155,093 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $399,107 | 244,851 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $547,759 | 224,492 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $618,879 | 253,639 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $532,980 | 198,134 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $1,131,329 | 237,176 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $639,494 | 207,628 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $425,856 | 137,373 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $574,370 | 164,576 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $657,052 | 215,427 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $293,053 | 155,055 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $119,744 | 42,766 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $250,291 | 60,457 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $172,382 | 36,992 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $172,037 | 28,389 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $217,871 | 20,829 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $602,640 | 29,226 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,398,221 | 76,694 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $1,297,488 | 55,782 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $498,995 | 22,021 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,480,547 | 64,681 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $424,854 | 19,462 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $288,804 | 24,600 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $336,208 | 29,492 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $196,036 | 17,566 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||